STOCK TITAN

Intuitive Surgical (ISRG) EVP logs PSU grant, RSU vesting and tax share offsets

Filing Impact
(Very High)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Intuitive Surgical executive Myriam Curet, EVP & Chief Medical Officer, reported several equity-related transactions in company stock and units. She received a grant of 2,793 performance stock units tied to performance goals that vest on February 28, 2026, three years after the original grant date.

Previously granted restricted stock units were converted into common shares as they vested, including 3,052 and 1,602 RSUs that settled at no cash exercise price. Related common shares are held indirectly by a trust. To satisfy statutory tax withholding, the trust delivered 1,514 and 795 shares at a price of $506.17 per share, with remaining net shares deposited into the holder’s account.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Curet Myriam

(Last) (First) (Middle)
1020 KIFER ROAD

(Street)
SUNNYVALE CA 94086

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
INTUITIVE SURGICAL INC [ ISRG ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP & Chief Medical Officer
3. Date of Earliest Transaction (Month/Day/Year)
02/26/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/26/2026 M(1) 3,052 A $0.0 3,461 I by Trust
Common Stock 02/26/2026 F(1) 1,514 D $506.17 1,947 I by Trust
Common Stock 02/26/2026 M(2) 1,602 A $0.0 3,549 I by Trust
Common Stock 02/26/2026 F(2) 795 D $506.17 2,754 I by Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Performance Stock Units - 2-28-2023 $0.0 02/26/2026 A 2,793 (3) (3) Common Stock 2,793 $0.0 8,378 D
Restricted Stock Units - 2-26-2024 $0.0 02/26/2026 M 3,052 (4) (4) Common Stock 3,052 $0.0 3,053 D
Restricted Stock Units - 2-26-2025 $0.0 02/26/2026 M 1,602 (5) (5) Common Stock 1,602 $0.0 0 D
Explanation of Responses:
1. RSUs vest 33% per year over a three year period. RSUs convert into common stock on the vest date on a one-for-one basis. 33% of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.
2. RSUs vest 100% on the first anniversary of the date of grant. RSUs convert into common stock on the vest date on a one-for-one basis. 100% of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.
3. Represents performance stock units ("PSUs") initially granted to the Reporting Person on February 28, 2023 subject to achievement of certain performance metrics. The performance criteria for the PSUs reported herein have been achieved, as determined by the Compensation Committee of the Issuer. The PSUs reported herein vest on February 28, 2026, the third anniversary of the grant date, subject to Reporting Person's continuous service to the Issuer through each such vesting date.
4. Each Restricted Stock Unit, granted pursuant to the 2010 Employee Stock Option Plan, represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 33% on the first anniversary of the date of grant and annually thereafter, over a three year period of time.
5. Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 100% on the first anniversary of the date of grant.
By: Stephanie Lim-Ignacio For: McAdams, Myriam Curet 02/27/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did ISRG executive Myriam Curet report?

Myriam Curet reported new performance stock unit awards and vesting of restricted stock units that converted into Intuitive Surgical common shares. Some shares were withheld to cover statutory tax obligations, with the remaining net shares deposited into an account held indirectly through a trust.

How many performance stock units did Myriam Curet receive at Intuitive Surgical (ISRG)?

She received a grant of 2,793 performance stock units, initially awarded on February 28, 2023. These units are subject to performance criteria and vest on February 28, 2026, contingent on her continued service with Intuitive Surgical through the three-year vesting period.

When do the reported Intuitive Surgical (ISRG) performance stock units vest?

The performance stock units vest on February 28, 2026, the third anniversary of the original February 28, 2023 grant. Vesting occurs after the Compensation Committee confirmed performance criteria were achieved and is also conditioned on Myriam Curet’s continuous service through the vesting date.

What happened to the Intuitive Surgical (ISRG) restricted stock units in this filing?

Restricted stock units converted into Intuitive Surgical common stock on their vesting dates on a one-for-one basis. Grants vest either 33% annually over three years or 100% after one year, with a portion of released shares used to satisfy statutory tax withholding obligations.

Why were some ISRG shares disposed of in Myriam Curet’s Form 4?

Shares were disposed of under code F to cover tax liabilities arising from RSU vesting, not as open-market sales. A trust delivered 1,514 and 795 shares at $506.17 per share to satisfy statutory tax withholding, with remaining net shares retained in the holder’s account.

How are Myriam Curet’s Intuitive Surgical (ISRG) shares held after these transactions?

Common shares resulting from RSU vesting are held indirectly by a trust associated with Myriam Curet. After withholding shares to cover taxes, the net common shares from vested RSUs were deposited into the account of the holder, as described in the footnotes.
Intuitive Surgical Inc

NASDAQ:ISRG

View ISRG Stock Overview

ISRG Rankings

ISRG Latest News

ISRG Latest SEC Filings

ISRG Stock Data

170.46B
352.77M
Medical Instruments & Supplies
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States
SUNNYVALE